Starpharma partners with UQ to advance DEP radio pipeline
Posted: 26 July 2023 Starpharma (ASX: SPL, OTCQX: SPHRY) today announces it has entered a new partnership with The University of Queensland’s (UQ’s) Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR Hub), which has been awarded $4.8 million from…
Immuron enrols first patients in Travelan clinical study
Posted: 26 July 2023 Immuron Ltd (NASDAQ:IMRN, ASX:IMC) has enrolled its first cohort of 30 participants into the Travelan® clinical trial to evaluate its efficacy to prevent infectious diarrhea caused by enterotoxigenic Escherichia coli (ETEC). Travelan® is known to…
Specialist Digital Health Workforce Census 2023
Posted: 26 July 2023 Are you part of the specialist digital health workforce? Are you responsible for health data, information, knowledge, or technology? Be part of the census that captures the vital information about this workforce. This information…
MTPConnect’s CTCM Program Awards $6.2M to Accelerate Homegrown Medical Device Innovations
Posted: 25 July 2023 MTPConnect and the Minister for Health and Aged Care, Hon. Mark Butler MP, today announced $6.2 million of funding for six medical technology projects through the Clinical Translation and Commercialisation Medtech (CTCM) Program. The CTCM program, a Medical…
Cardihab and Roche Diagnostics Partner on Cardiovascular Disease
Posted: 25 July 2023 Digital health company Cardihab has recently announced a partnership with Roche Diagnostics Australia Pty Ltd that is focused on improving quality and standards of care, that deliver better outcomes for people living with cardiovascular conditions in Australia.…
Breakthrough lung disease scanner
Posted: 25 July 2023 The Albanese Government has provided $1.1 million towards development of a new scanner which could revolutionise diagnosis of deadly lung conditions around the world. The XV-Perfusion lung scanner measures both ventilation (air flow) and…
AusBiotech launches National Cell and Gene Manufacturing Blueprint
Posted: 24 July 2023 A new National Cell and Gene Manufacturing Blueprint launched today, outlining how, with a united and coordinated plan, Australia can realise its potential to become a cell and gene (C&G) manufacturing hub for within…
Bacteria discreetly dwelling in throat revealed to be primary source of Strep A transmission
Posted: 24 July 2023 Breakthrough research has found that Group A Streptococcus (GAS) infections are more likely transmitted from asymptomatic throat carriage than skin-to-skin contact in communities with high rates of infection. This major discovery has far-reaching implications…
DMX-200 FSGS ACTION3 Phase 3 Kidney Trial Part 1 Outcome Set for Q1 2024
Posted: 24 July 2023 Dimerix Limited (ASX: DXB) a biopharmaceutical company with a Phase 3 clinical study in inflammatory diseases, today confirmed that the first 72 patients have been randomised in its DMX-200 ACTION3 phase 3 trial in…
DEP® HER2-radiodiagnostic shows imaging benefits
Posted: 24 July 2023 Starpharma (ASX: SPL, OTCQX: SPHRY) today announces that DEP® HER2-zirconium, its HER2-targeted radiodiagnostic candidate, has demonstrated a favourable biodistribution profile, with excellent imaging contrast between tumour and normal tissues, as well as rapid uptake and high levels…
Ginkgo Bioworks Awarded DARPA Contract to Reimagine the Manufacturing of Complex Therapeutic Proteins
Posted: 24 July 2023 The Defense Advanced Research Projects Agency (DARPA) announced that Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, has been awarded a 4-year contract worth up to $18…
First Patient Dosed in STARSTRUCK Study of TLX250 Targeted Radiation Therapy in Combination with Merck Investigational DNA-PK Inhibitor, Peposertib
Posted: 24 July 2023 Telix today announces that the first patient has been dosed in a Phase I study of the Company’s investigational targeted radiation therapy, TLX250, in combination with a Merck KGaA, Darmstadt, Germany (Merck) DNA-dependent protein…
